Based on the significant differences in metabolic biomarkers between ND-DKD and newly diagnosed type 2 diabetes mellitus patients, our study selected insulin, C-peptide, and lipoproteins to explore potential biomarkers for predicting DKD (30). The gene discussed is INS; the disease is diabetes mellitus.